DOI: http://dx.doi.org/10.18203/2349-3291.ijcp20200210

Serum magnesium levels in attention deficit hyperactive disorder in 6-17 years age group: a study in tertiary care center

Ajay Mohan Varahala, Ravi Gajula, Subba Rao K.V.

Abstract


Background: Attention-deficit/hyperactivity disorder (ADHD) is the most common neurobehavioral disorder of childhood and one of among the most prevalent chronic health conditions affecting school-age children. Magnesium is a crucial mineral and appropriate levels in the body are essential for normal cognitive function and mental health. Seventy-two to 96% of those diagnosed with ADHD have been found to be significantly deficient in magnesium. Studies have shown that in these patients, supplementation with magnesium improves attention and working memory and decreases anxiety, depression and emotional dysregulation. Objective of the study was to measure the serum levels of magnesium in children with attention deficit hyperactive disorder and to assess the relation between serum Magnesium levels and Attention deficit hyperactive disorder (ADHD).

Methods: The study was conducted at Niloufer Institute of Child Health, which is tertiary care referral hospital and a teaching institute, affiliated under the esteemed Osmania Medical College, Hyderabad. Ethical committee clearance was taken before conducting the study, 50 cases of ADHD are selected from the outpatient department of the Psychiatry clinic for children and adolescents. And 50 controls are also selected for this study. Serum magnesium levels are assessed in both groups.

Results: In ADHD group children with serum Magnesium level <1.5 meq/L are 24% whereas in control group it is 6%. When subgroups were analyzed, 25% of hyperactive ADHD group, 18.75% of inattentive ADHD group and 27.27% of combined ADHD group had serum magnesium levels of less than 1.5 meq/l.

Conclusions: The study suggest that there is deficiency of magnesium in ADHD children when compared to healthy controls. Further, the study also recommends that further research is needed to help to identify the etiology, impact, and possible therapeutic implications of magnesium status in ADHD.

Keywords


Attention deficit hyperactive disorder, Children, Cognitive functions, Mental health, Serum magnesium levels

Full Text:

PDF

References


Ghanizadeh A. Association of nail biting and psychiatric disorders in children and their parents in a psychiatrically referred sample of children. Child Adolesc Psychiatry Ment Health. 2008;2:13.

Rucklidge JJ, Johnstone J, Kaplan BJ. Nutrient supplementation approaches in the treatment of ADHD. Expert Rev Neurother. 2009;9(4):461-76.

Banaschewski T, Roessner V, Dittmann RW, Santosh PJ, Rothenberger A. Non-stimulant medications in the treatment of ADHD. Eur Child Adolesc Psychiatry. 2004;13 (Suppl 1):I102-16.

Hurt EA, Arnold LE, Lofthouse N. Dietary and nutritional treatments for attention-deficit/hyperactivity disorder: current research support and recommendations for practitioners. Curr Psychiatr Rep. 2011;13(5):323-32.

Swaminathan R. Magnesium metabolism and its disorders, Department of Chemical Pathology, St Thomas’ Hospital, London, SE1 7EH.UK. Clin Bio Rev. 2003;24(2):47-66.

Eby GA, 3rd Eby KL. Magnesium for treatment-resistant depression: a review and hypothesis. Med Hypotheses. 2010;74:649-60.

Cardoso CC, Lobato KR, Binfare RW, Ferreira PK, Rosa AO, Santos AR, et al. Evidence for the involvement of the monoaminergic system in the antidepressant-like effect of magnesium. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:235-42.

Sinn N. Nutritional and dietary influences on attention deficit hyperactivity disorder. Nutr Rev. 2008;66(10):558-68.

Huss M, Völp A, Stauss-Grabo M. Supplementation of polyunsaturated fatty acids, magnesium and zinc in children seeking medical advice for attention-deficit/hyperactivity problems-an observational cohort study. Lipids Health Dis. 2010 Dec 1;9(1):105.

Vink R, O’Connor CA, Nimmo AJ, Heath DL. Magnesium attenuates persistent functional deficits following diffuse traumatic brain injury in rats. Neurosci Lett. 2003 Jan 9;336(1):41-4.

Lord RS, Bralley JA. Clinical applications of urinary organic acids. Part 2. Dysbiosis markers. Altern Med Rev. 2008 Dec;13(4):292-306.

El Adham EK, Hassan AI, El- Mahdy AA. Nutritional and metabolic disturbances in attention deficit hyperactivity disease. Res J Med Med Sci. 2011;6(1):10-6

Zaki AA, Salah N, Elshahawi H. Sleep disturbances in children with attention deficit hyperactivity disorder. Egypt J Neurol Psychiatry Neurosur. 2005;42(2):527-36.

Kozielec T. Assessment of magnesium levels in children with attention deficit hyperactivity disorder. Magnes Res. 1997;10(2):143-8.

Mahmoud MM, Abdel-Azeem AA, Maher Reham M, Saber Manal M. Zinc, ferritin, magnesium and copper in a group of Egyptian children with attention deficit hyperactivity disorder. Ital J Pediatr. 2011;37:60-7.

El Baza F, AlShahawi HA, Zahra S, Abdel Hakim RA. Magnesium supplementation in children with attention deficit hyperactivity disorder. Egypt J Med Hum Genet. 2016;17(1):63-70.

Elbaz F, Zahra S, Hanafy H. Magnesium, zinc and copper estimation in children with attention deficit hyperactivity disorder (ADHD). Egypt J Med Human Genet. 2017;18(2):153-63.

Archana E, Pai P, Prabhu BK, Shenoy RP, Prabhu K, Rao A. Altered biochemical parameters in saliva of pediatric attention deficit hyperactivity disorder. Neurochem Res. 2012;37:330-4.

Nogovitsina OR, Levitina EV. Neurological aspect of clinical symptoms, pathophysiology and correction in attention deficit hyperactivity disorder. Zh Nevrol Psikhiatr Im S S Korsakova. 2006;106:17-20.

Mousain-Bosc M, Roche M, Polge A, Pradal-Prat D, Rapin J, Bali JP. Improvement of neurobehavioral disorders in children supplemented with magnesium-vitamin B6. Mag Res. 2006 Mar 1;19(1):46-52.

Irmisch G, Thome J, Reis O, Hassler F, Weirich S. Modified Magnesium and lipoproteins in children with attention deficit hyperactivity disorder (ADHD). World J Biol Psychiatr. 2011;12(Suppl 1):63-5.

Antalis CJ, Stevens LJ, Campbell M, Pazdro R, Ericson K, Burgess JR. Omega-3 fatty acid status in Attention-deficit/Hyperactivity disorder. Prostaglandins Leukot Essent Fatty Acids. 2006;75:299-308.

Riley C, DuPaul GJ, Pipan M, Kern L, Van Brakle J, Blum NJ. Combined type versus ADHD predominantly hyperactive-impulsive type: is there a difference in functional impairment? J Dev Behav Pediatr. 2008, 29(4):270-5.

Mousain-Bosc M, Roche M, Rapin J, Bali JP. Magnesium VitB6 intake reduces central nervous system hyperexcitability in children. J Am Coll Nutr. 2004 Oct 1;23(5):545S-8S.